Fair Value Measurements (Details) (USD $) | Dec. 31, 2014 | Dec. 31, 2013 |
In Thousands, unless otherwise specified |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | | |
Securities and derivatives owned by partnership investments (Note 7) | $143,723 | $46,425 |
Recurring | Quoted Prices in Active Markets for Identical Assets and Liabilities (Level 1) | | |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | | |
Cash and cash equivalents | 1,209 | 1,752 |
Investment securities (Note 5) | 337,927 | 472,241 |
Securities and derivatives owned by partnership investments (Note 7) | 37,083 | 29,299 |
Securities sold but not yet purchased by partnership investments (Note 7) | | -10,726 |
Total | 373,251 | 492,566 |
Recurring | Quoted Prices in Active Markets for Identical Assets and Liabilities (Level 1) | Global Growth | | |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | | |
Investment securities (Note 5) | 146,013 | 225,892 |
Recurring | Quoted Prices in Active Markets for Identical Assets and Liabilities (Level 1) | U.S. Growth | | |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | | |
Investment securities (Note 5) | 112,526 | 97,936 |
Recurring | Quoted Prices in Active Markets for Identical Assets and Liabilities (Level 1) | Value | | |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | | |
Investment securities (Note 5) | 12,218 | 9,959 |
Recurring | Quoted Prices in Active Markets for Identical Assets and Liabilities (Level 1) | Alternative | | |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | | |
Investment securities (Note 5) | 42,031 | 37,436 |
Recurring | Quoted Prices in Active Markets for Identical Assets and Liabilities (Level 1) | Fixed Income/High Yield | | |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | | |
Investment securities (Note 5) | 12,174 | 99,260 |
Recurring | Quoted Prices in Active Markets for Identical Assets and Liabilities (Level 1) | Convertible | | |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | | |
Investment securities (Note 5) | 11,021 | 145 |
Recurring | Quoted Prices in Active Markets for Identical Assets and Liabilities (Level 1) | Multi-Strategy | | |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | | |
Investment securities (Note 5) | 1,683 | 1,400 |
Recurring | Quoted Prices in Active Markets for Identical Assets and Liabilities (Level 1) | Total Funds | | |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | | |
Investment securities (Note 5) | 337,666 | 472,028 |
Recurring | Quoted Prices in Active Markets for Identical Assets and Liabilities (Level 1) | Common Stock | | |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | | |
Investment securities (Note 5) | 261 | 213 |
Securities and derivatives owned by partnership investments (Note 7) | 26,237 | 29,149 |
Securities sold but not yet purchased by partnership investments (Note 7) | -2,968 | -10,185 |
Recurring | Quoted Prices in Active Markets for Identical Assets and Liabilities (Level 1) | Preferred stocks | | |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | | |
Securities and derivatives owned by partnership investments (Note 7) | 2,281 | |
Recurring | Quoted Prices in Active Markets for Identical Assets and Liabilities (Level 1) | Convertible bonds | | |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | | |
Securities and derivatives owned by partnership investments (Note 7) | 0 | |
Recurring | Quoted Prices in Active Markets for Identical Assets and Liabilities (Level 1) | Corporate bonds | | |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | | |
Securities and derivatives owned by partnership investments (Note 7) | 0 | |
Recurring | Quoted Prices in Active Markets for Identical Assets and Liabilities (Level 1) | Foreign currency | | |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | | |
Securities and derivatives owned by partnership investments (Note 7) | 513 | |
Recurring | Quoted Prices in Active Markets for Identical Assets and Liabilities (Level 1) | Money market funds | | |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | | |
Securities and derivatives owned by partnership investments (Note 7) | 7,851 | |
Recurring | Quoted Prices in Active Markets for Identical Assets and Liabilities (Level 1) | Exchange-traded put option contracts | | |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | | |
Securities and derivatives owned by partnership investments (Note 7) | 201 | 150 |
Recurring | Quoted Prices in Active Markets for Identical Assets and Liabilities (Level 1) | Exchange-traded call option contracts | | |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | | |
Securities sold but not yet purchased by partnership investments (Note 7) | | -56 |
Recurring | Quoted Prices in Active Markets for Identical Assets and Liabilities (Level 1) | Exchange-traded funds | | |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | | |
Securities sold but not yet purchased by partnership investments (Note 7) | | -485 |
Recurring | Significant Other Observable Inputs (Level 2) | | |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | | |
Cash and cash equivalents | 0 | 0 |
Investment securities (Note 5) | 5,000 | 0 |
Securities and derivatives owned by partnership investments (Note 7) | 103,770 | 0 |
Securities sold but not yet purchased by partnership investments (Note 7) | | 0 |
Total | 108,770 | 0 |
Recurring | Significant Other Observable Inputs (Level 2) | Global Growth | | |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | | |
Investment securities (Note 5) | 0 | 0 |
Recurring | Significant Other Observable Inputs (Level 2) | U.S. Growth | | |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | | |
Investment securities (Note 5) | 0 | 0 |
Recurring | Significant Other Observable Inputs (Level 2) | Value | | |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | | |
Investment securities (Note 5) | 0 | 0 |
Recurring | Significant Other Observable Inputs (Level 2) | Alternative | | |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | | |
Investment securities (Note 5) | 0 | 0 |
Recurring | Significant Other Observable Inputs (Level 2) | Fixed Income/High Yield | | |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | | |
Investment securities (Note 5) | 5,000 | 0 |
Recurring | Significant Other Observable Inputs (Level 2) | Convertible | | |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | | |
Investment securities (Note 5) | 0 | 0 |
Recurring | Significant Other Observable Inputs (Level 2) | Multi-Strategy | | |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | | |
Investment securities (Note 5) | 0 | 0 |
Recurring | Significant Other Observable Inputs (Level 2) | Total Funds | | |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | | |
Investment securities (Note 5) | 5,000 | 0 |
Recurring | Significant Other Observable Inputs (Level 2) | Common Stock | | |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | | |
Investment securities (Note 5) | 0 | 0 |
Securities and derivatives owned by partnership investments (Note 7) | 25,166 | 0 |
Securities sold but not yet purchased by partnership investments (Note 7) | 0 | 0 |
Recurring | Significant Other Observable Inputs (Level 2) | Preferred stocks | | |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | | |
Securities and derivatives owned by partnership investments (Note 7) | 3,455 | |
Recurring | Significant Other Observable Inputs (Level 2) | Convertible bonds | | |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | | |
Securities and derivatives owned by partnership investments (Note 7) | 41,119 | |
Recurring | Significant Other Observable Inputs (Level 2) | Corporate bonds | | |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | | |
Securities and derivatives owned by partnership investments (Note 7) | 4,821 | |
Recurring | Significant Other Observable Inputs (Level 2) | Foreign currency | | |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | | |
Securities and derivatives owned by partnership investments (Note 7) | 0 | |
Recurring | Significant Other Observable Inputs (Level 2) | Money market funds | | |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | | |
Securities and derivatives owned by partnership investments (Note 7) | 29,209 | |
Recurring | Significant Other Observable Inputs (Level 2) | Exchange-traded put option contracts | | |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | | |
Securities and derivatives owned by partnership investments (Note 7) | 0 | 0 |
Recurring | Significant Other Observable Inputs (Level 2) | Exchange-traded call option contracts | | |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | | |
Securities sold but not yet purchased by partnership investments (Note 7) | | 0 |
Recurring | Significant Other Observable Inputs (Level 2) | Exchange-traded funds | | |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | | |
Securities sold but not yet purchased by partnership investments (Note 7) | | 0 |
Recurring | Estimate of Fair Value Measurement | | |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | | |
Cash and cash equivalents | 1,209 | 1,752 |
Investment securities (Note 5) | 342,927 | 472,241 |
Securities and derivatives owned by partnership investments (Note 7) | 140,853 | 29,299 |
Securities sold but not yet purchased by partnership investments (Note 7) | | -10,726 |
Total | 482,021 | 492,566 |
Recurring | Estimate of Fair Value Measurement | Global Growth | | |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | | |
Investment securities (Note 5) | 146,013 | 225,892 |
Recurring | Estimate of Fair Value Measurement | U.S. Growth | | |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | | |
Investment securities (Note 5) | 112,526 | 97,936 |
Recurring | Estimate of Fair Value Measurement | Value | | |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | | |
Investment securities (Note 5) | 12,218 | 9,959 |
Recurring | Estimate of Fair Value Measurement | Alternative | | |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | | |
Investment securities (Note 5) | 42,031 | 37,436 |
Recurring | Estimate of Fair Value Measurement | Fixed Income/High Yield | | |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | | |
Investment securities (Note 5) | 17,174 | 99,260 |
Recurring | Estimate of Fair Value Measurement | Convertible | | |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | | |
Investment securities (Note 5) | 11,021 | 145 |
Recurring | Estimate of Fair Value Measurement | Multi-Strategy | | |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | | |
Investment securities (Note 5) | 1,683 | 1,400 |
Recurring | Estimate of Fair Value Measurement | Total Funds | | |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | | |
Investment securities (Note 5) | 342,666 | 472,028 |
Recurring | Estimate of Fair Value Measurement | Common Stock | | |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | | |
Investment securities (Note 5) | 261 | 213 |
Securities and derivatives owned by partnership investments (Note 7) | 51,403 | 29,149 |
Securities sold but not yet purchased by partnership investments (Note 7) | -2,968 | -10,185 |
Recurring | Estimate of Fair Value Measurement | Preferred stocks | | |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | | |
Securities and derivatives owned by partnership investments (Note 7) | 5,736 | |
Recurring | Estimate of Fair Value Measurement | Convertible bonds | | |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | | |
Securities and derivatives owned by partnership investments (Note 7) | 41,119 | |
Recurring | Estimate of Fair Value Measurement | Corporate bonds | | |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | | |
Securities and derivatives owned by partnership investments (Note 7) | 4,821 | |
Recurring | Estimate of Fair Value Measurement | Foreign currency | | |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | | |
Securities and derivatives owned by partnership investments (Note 7) | 513 | |
Recurring | Estimate of Fair Value Measurement | Money market funds | | |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | | |
Securities and derivatives owned by partnership investments (Note 7) | 37,060 | |
Recurring | Estimate of Fair Value Measurement | Exchange-traded put option contracts | | |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | | |
Securities and derivatives owned by partnership investments (Note 7) | 201 | 150 |
Recurring | Estimate of Fair Value Measurement | Exchange-traded call option contracts | | |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | | |
Securities sold but not yet purchased by partnership investments (Note 7) | | -56 |
Recurring | Estimate of Fair Value Measurement | Exchange-traded funds | | |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | | |
Securities sold but not yet purchased by partnership investments (Note 7) | | ($485) |